PRESS RELEASE
News
-
-
-
PRESS RELEASE
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
ABIONYX Pharma communique le nombre de droits de vote et d'actions en circulation, conformément aux exigences de l'AMF. La société se consacre au développement de biomédicaments novateurs pour les maladies inflammatoires les plus sévères -
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Monthly statement of total voting rights and shares for ABIONYX Pharma on Euronext Paris, including total gross and net voting rights as of April 30, 2025 -
-
-
PRESS RELEASE
Vonovia SE: Strong start to the year and optimistic outlook for 2025 lay the foundation for forward-looking succession planning
Vonovia SE announces appointment of Luka Mucic as new CEO, positive Q1 2025 results, and growth strategy 2028. Succession planning amid stable property values and optimistic outlook -
-
-
